Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023127
Filing Date
2025-05-07
Accepted
2025-05-07 16:01:21
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cdcx-20250331.htm   iXBRL 10-Q 1189750
2 EX-4.1 formofstockcertificateni.htm EX-4.1 6253
3 EX-10.3 ex-103xsecondleaseamendment.htm EX-10.3 45220
4 EX-10.4 ex-104seventhmodificationt.htm EX-10.4 58929
5 EX-10.5 ex-1052017equityincentivep.htm EX-10.5 199648
6 EX-10.6 ex-106stockoptionagreement.htm EX-10.6 46468
7 EX-10.7 ex-107restrictedstockunita.htm EX-10.7 42466
8 EX-10.8 ex-108nonxemployeedirector.htm EX-10.8 16854
9 EX-10.9 ex-109amendedincentivecomp.htm EX-10.9 28396
10 EX-31.1 nageex-311q12025.htm EX-31.1 10554
11 EX-31.2 nageex-312q12025.htm EX-31.2 10502
12 EX-32.1 nageex-321q12025.htm EX-32.1 5739
18 cdcx-20250331_g1.jpg GRAPHIC 143741
19 formofstockcertificateni001.jpg GRAPHIC 229003
  Complete submission text file 0001628280-25-023127.txt   7153790

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdcx-20250331.xsd EX-101.SCH 37876
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdcx-20250331_cal.xml EX-101.CAL 52431
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdcx-20250331_def.xml EX-101.DEF 161362
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdcx-20250331_lab.xml EX-101.LAB 526379
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdcx-20250331_pre.xml EX-101.PRE 352953
76 EXTRACTED XBRL INSTANCE DOCUMENT cdcx-20250331_htm.xml XML 872924
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
Niagen Bioscience, Inc. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37752 | Film No.: 25921106
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)